STZ OcuTox: Drug development know-how
STZ OcuTox is a Steinbeis company located at the University Hospital Tübingen, and supplies industrial partners with drug development know-how.
It specialises in preclinical ophthalmological examinations on various experimental animals, and carries out all kinds of electron microscopic and ophthalmological examinations. This helps, combined with molecular biological techniques, in understanding the mode of action of toxicological and other pathological changes in eye tissue.
The testing procedures are available for most experimental animals and animal models, or can be acquired in a short time.
ScanBalt News
19 February 2025
Unlocking Opportunities: Latest Trends & Developments in Sweden’s Life Sciences & Health Sectors | 7 March 2025, 10:00-11:00 CET (online)
18 October 2024
Unlocking Europe's Potential in Bioproduction | 12 November 2024 | 10:30-12:00 CET (online)
10 October 2024
NOME Startup Competition 2024 | Dealine November 1st